Overall Perfomance for "Ultimate Stock Alerts"
The following three charts can be used by potential investors to gauge the performance of "Ultimate Stock Alerts":
1 out of 5 campaigns closed down on first day
2 out of 5 campaigns closed up on first day
2 out of 5 campaigns had no net effect
PURE Promotional Newsletter
The following is a newsletter released by "Ultimate Stock Alerts" promoting PURE Bioscience
Don't Want Anymore Emails
New Alert BioSig Technologies, Inc. NASDAQ BSGM
We wanted to send you this new opportunity that released potentially big news earlier today that could be a large growth catalyst.
BSGM is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.
By providing clearer biomedical signals, the companys advanced signal processing capabilities can help clinicians better understand and change patterns to treat, or even prevent diseases.
Bioelectronic medicine is a new approach to treating and diagnosing disease and injury.
This new field uses device technology to read and modulate the electrical activity within the bodys nervous system, opening new doors to real-time diagnostics and treatment options for patients.
One of the exciting aspects of bioelectronic medicine is its potential to supplement and even replace drugs, including their cost and often debilitating side effects.
Bioelectronic medicine could deliver treatment breakthroughs for many diseases that currently have a high level of unmet need.
The companys first product, the PURE EPtm System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology EP procedures in an EP laboratory.
The PURE EP System is being used in all types of arrhythmia cases, including atrial fibrillation, ventricular tachycardia, and atrial flutter.
The Company is in a focused commercial launch of the PURE EPtm System in the Northeast, Texas, and Florida, and the technology is in regular use in some of the countrys leading centers of excellence, including the Mayo Clinic in Rochester, MN, and St. Davids Medical Center in Austin, TX.
To date, over 71 physicians have completed over 1600 patient cases with the PURE EPtm System across thirteen clinical sites.
Since our last update, the company has announced multiple accomplishments recently.
In September, the company announced
BioSig Increases Installation Footprint Adding St. Elizabeths Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
BioSig Selects Plexus Corp. as its Manufacturing Partner
In October, the company announced
Clinical Data Acquired by the PURE EP System Published in the Journal of Cardiac Electrophysiology
BioSigs PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias
Most recently, on Monday, the company announced
BioSig Increases Case Volume Estimates
The Company reports increased adoption and commercial activity of its signal processing technology for arrhythmia care
Here are the companys comments from this press release
We are seeing increased utilization of PURE EPtm in the 13 hospitals we are currently working in. Physicians recognize value both clinically and economically or they would not be increasing their usage. Hospitals are rapidly scaling their elective procedures and thus we are now seeing increased case volumes and commercial activity, commented Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc.
In addition, just this morning, the company announced potentially big news
BioSig Expands its Installation Base in Texas
Westport, CT, Nov. 04, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the Company is installing a PURE EPtm System for an evaluation at the Methodist Hospital in San Antonio, TX, one of the largest hospitals in the United States in terms of the number of available beds. This 90-day evaluation agreement brings the Company up to 15 installed centers.
Here are the companys comments from this press release
Texas is one of the three strategic areas that we are focusing on in the targeted commercial launch phase, and we are very pleased to welcome another Texas center to our customer base. Methodist Hospital conducted over 1800 cardiac ablations last year, and some of our greatest accomplishments have been achieved at similarly high-volume centers. We look forward to bringing our technology to more physicians in Texas to advance our clinical and commercial strategies further, commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.
BSGM could be in a position to experience increased growth.
Make sure to do your own due diligence.
Sources , , , , , , , , ,
Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
You should read and understand this disclaimer in its entirety before joining the website or emailblog list of UltimateStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated eleven thousand five hundred dollars by bank wire transfer on 11421 for the distribution of this advertisement about BSGM dated 11421. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 62321 for the distribution of a prior advertisement about BSGM. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 122920 for the distribution of a prior advertisement about BSGM. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about BSGM. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
www.UltimateStockAlerts.comDisclaimer and www.UltimateStockAlerts.comPrivacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.
Our records indicate that . requested and confirmed to be added to UltimateStockAlerts.com on January 26, 2015.
6020 Bent Pine Dr, Orlando, FL 32822, USA
Last 1 Stock Promotions By "Ultimate Stock Alerts"
|BTCY||Biotricity Inc.||September 16, 2021||3.58||0%|